SIP
BMY icon

Stoneridge Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Stoneridge Investment Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-146,029
Closed -$7.56M – 142
2024
Q3 		$7.56M Sell
146,029
-1,544
-1% -$72.4K 2.81% 7
2024
Q2 		$6.13M Buy
147,573
+100,951
+217% +$4.52M 2.32% 10
2024
Q1 		$2.53M Buy
+46,622
New +$2.37M 0.96% 37
2022
Q1 		– Sell
-36,050
Closed -$2.25M – 107
2021
Q4 		$2.25M Buy
+36,050
New +$2.11M 1.04% 29
2021
Q3 		– Sell
-11,835
Closed -$791K – 114
2021
Q2 		$791K Buy
+11,835
New +$772K 0.38% 72
2021
Q1 		– Sell
-14,073
Closed -$873K – 113
2020
Q4 		$873K Sell
14,073
-10,852
-44% -$667K 0.51% 62
2020
Q3 		$1.5M Buy
+24,925
New +$1.5M 0.99% 32
2020
Q1 		– Sell
-22,457
Closed -$1.44M – 117
2019
Q4 		$1.44M Sell
22,457
-500
-2% -$28.6K 0.49% 66
2019
Q3 		$1.16M Sell
22,957
-86,310
-79% -$4.06M 0.43% 78
2019
Q2 		$4.96M Buy
+109,267
New +$5.09M 1.76% 13
2018
Q4 		– Sell
-43,681
Closed -$2.71M – 122
2018
Q3 		$2.71M Sell
43,681
-18,827
-30% -$1.12M 0.58% 64
2018
Q2 		$3.46M Buy
+62,508
New +$3.38M 0.67% 62
2017
Q2 		– Sell
-60,726
Closed -$3.3M – 261
2017
Q1 		$3.3M Buy
60,726
+54,557
+884% +$2.99M 0.45% 84
2016
Q4 		$361K Sell
6,169
-186,836
-97% -$10.2M 0.05% 237
2016
Q3 		$10.4M Buy
+193,005
New +$12.4M 1.51% 7

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Stoneridge Investment Partners's BMY Position: Q4 2024 in Review

Stoneridge Investment Partners sold out of Bristol-Myers Squibb (BMY) in Q4 2024, closing a stake of 146,029 shares — an estimated $7.56M sold.

Stoneridge Investment Partners first reported a position in BMY in Q3 2016 and held it in 15 quarters. The position peaked at $10.4M in Q3 2016. 2,487 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

  • Stoneridge Investment Partners reported no remaining Bristol-Myers Squibb position as of Q4 2024 after selling out during the quarter.
  • Stoneridge Investment Partners sold 146,029 Bristol-Myers Squibb shares in Q4 2024, an estimated $7.56M.
  • Stoneridge Investment Partners first reported a position in Bristol-Myers Squibb in Q3 2016 and held it in 15 quarters.
  • Stoneridge Investment Partners's Bristol-Myers Squibb position peaked at $10.4M in Q3 2016.
  • 2,487 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on Stoneridge Investment Partners's 13F filing for Q4 2024, filed 28 Jan 2025.